Who owns Kalvista Pharmaceuticals?
- CUSIP Number: 483497103
Tip: Access positions for across all investors
Analyze quarterly positions in Kalvista Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kalvista Pharmaceuticals stock
Who bought or sold Kalvista Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Capital World Investors | 2.8M | $57M | 0% | Mar 2026 |
|
| State Street Corporation | 2.0M | $39M | 2% | Mar 2026 |
|
| Morgan Stanley | 439k | $8.8M | -37% | Mar 2026 |
|
| Citigroup | 244k | $4.9M | 100% | Mar 2026 |
|
| T. Rowe Price Associates | 29k | $592k | 27% | Mar 2026 |
|
| Henderson Group | 11k | $220k | 100% | Mar 2026 |
|
| Mirae Asset Global Investments | 2.6k | $53k | 7% | Mar 2026 |
|
| CWM | 901.00 | $18k | 37% | Mar 2026 |
|
| Parkside Financial Bank & Trust | 40.00 | $805.000000 | 0% | Mar 2026 |
|
| Sunbelt Securities | 9.00 | $180.999900 | 0% | Mar 2026 |
|
| IFP Advisors | 7.00 | $189.000000 | 100% | Jun 2026 |
|